Physician profile
Sonja Perkins
NPI 1952397911
$7,557.41
in general payments reported to CMS, 2019-2025
36 companies · $470 in 2025
The $470 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $3,048 · 2021: $2,244 · 2022: $549 · 2023: $535 · 2024: $176 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2020 | |
| Davol INC. | $2,061.53 | 2021 | |
| Abbvie INC. | $434.17 | 2019-2025 | |
| Pfizer INC. | $215.67 | 2021-2024 | |
| Therapeuticsmd, INC. | $165.02 | 2019 | |
| Medtronic, INC. | $134.20 | 2022 | |
| Hologic Sales and Service, LLC | $125.94 | 2023-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Baxter Healthcare | $122.49 | 2019 | |
| Sumitomo Pharma America, INC. | $107.88 | 2023-2024 | Myfembree |
| Novo Nordisk INC | $107.27 | 2020-2024 | Wegovy |
| Mayne Pharma Commercial LLC | $100.37 | 2025 | |
| Myovant Sciences INC. | $92.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.40 | 2019-2025 | |
| Coopersurgical, INC. | $77.19 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Agile Therapeutics, INC. | $74.65 | 2021-2023 | Twirla |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $72.80 | 2023-2024 | Veozah |
| Mylan Pharmaceuticals INC. | $62.44 | 2019-2022 | |
| Gynesonics, INC. | $49.83 | 2021-2022 | |
| Monaghan Medical Corporation | $44.29 | 2023 | Aeroeclipse, Aerobika |
| Organon LLC | $42.19 | 2023-2025 | Jada System, Nexplanon |
| Exact Sciences Corporation | $39.99 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $39.63 | 2024-2025 | |
| Mimedx Group, INC. | $35.37 | 2025 | |
| Evofem Biosciences, INC. | $32.75 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $30.82 | 2019-2020 | |
| Meditrina | $27.73 | 2023 | |
| Gilead Sciences, INC. | $25.23 | 2025 | |
| Bsn Medical INC | $22.03 | 2025 | |
| Millicent US INC | $21.88 | 2025 | Femlyv |
| Minerva Surgical, INC | $19.16 | 2022 | |
| Lilly USA, LLC | $18.37 | 2025 | Zepbound |
| Roche Diagnostics Corporation | $15.54 | 2021 | |
| Scynexis, INC. | $14.26 | 2022 | |
| Horizon Therapeutics Plc | $14.16 | 2021 | |
| Lupin INC. | $12.30 | 2019 | |
| Exeltis, USA INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonja Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.